- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02997904
A Clinical Trial Evaluating the Efficacy of Resultz Lice and Egg Elimination Kit on Pediatric and Adult Subjects
July 31, 2017 updated by: Piedmont Pharmaceuticals, LLC
A Randomized Sham Controlled Double Blinded Single Site Clinical Trial Evaluating the Efficacy of Resultz Lice and Egg Elimination Kit for the Removal of Human Head Lice and Eggs on Pediatric and Adult Subjects
A one day study to demonstrate that Resultz Lice and Egg Elimination Kit is statistically superior to a sham control with one hour of combing.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Resultz Lice and Egg Elimination Kit will be efficacious in the removal of human head lice infestations in children and adult subjects under simulated real world conditions.
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
West Palm Beach, Florida, United States, 33407
- Lice Solution Resource Network Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 90 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Must have active head lice infestations (at least 1 live louse and eggs)
- Good general health based on medical history
- Each subject has to be consented
Exclusion Criteria:
- Subjects with any condition that would compromise the study
- History of irritation or sensitivity to pediculicides or hair care products
- Subjects with cranial or facial implants
- Subjects who have received radiation within the last 6 months
- Subjects with history of heart disease
- Subjects with history of epilepsy or seizure disorders
- Subjects with neuro-stimulator or pacemaker
- Subject with hair that staff cannot comb
- Subject previously treated in study in last 30 days
- Use of lice treatment in past 2 weeks
- Subject unable to sense pain
- Subject unable to communicate pain
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Resultz Lice and Egg Elimination Kit
Resultz combing solution, head lice comb and instructions for use in a kit: apply liquid then comb out for 1 hour
|
Apply liquid to dry hair, wait for 5 minutes, then comb out lice and eggs for up to one hour
Other Names:
|
|
Placebo Comparator: Placebo Lice and Egg Elimination Kit
20% glycerin combing solution, comb and instructions for use in a kit: apply liquid then comb out for 1 hour
|
Apply liquid to dry hair, wait for 5 minutes, then comb out lice and eggs for up to one hour
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Total Number of Lice + Eggs Removed From the Head After One Hour of Combing
Time Frame: 1 hour
|
A superiority analysis comparing the total number of lice + eggs removed from the head after one hour of combing with the Resultz Kit versus the control.
The Resultz Kit was considered a success if the Resultz Kit was superior to the control.
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total Number of Lice Removed, Total Number of Eggs Removed
Time Frame: 1 hour
|
Total number of lice removed after one hour of combing and total number of eggs removed after one hour of combing, analyzed separately
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Katie Shepherd, Lice Solutions Resource Network Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2016
Primary Completion (Actual)
January 1, 2017
Study Completion (Actual)
February 1, 2017
Study Registration Dates
First Submitted
December 16, 2016
First Submitted That Met QC Criteria
December 19, 2016
First Posted (Estimate)
December 20, 2016
Study Record Updates
Last Update Posted (Actual)
August 31, 2017
Last Update Submitted That Met QC Criteria
July 31, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- PP-16-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediculus Capitis
-
ParaSonic Ltd.Completed
-
ParaPRO LLCCompletedPediculus Capitis InfestationUnited States
-
Indonesia UniversityCompletedPruritus | Pediculus CapitisIndonesia
-
Topaz Pharmaceuticals IncCompletedPediculus Humanus Capitis (Head Lice)United States
-
Boston Scientific CorporationCompletedHead Lice | Pediculus Humanus CapitisUnited States
-
Phramongkutklao College of Medicine and HospitalActive, not recruitingIvermectin | School-age Children | Pediculus Capitis Infestation | Permethrin Adverse Reaction | Dimethicone Adverse Reaction | Permethrin Allergy | Dimethicone AllergyThailand
-
Alexandria UniversityRecruiting
-
National institute of SiddhaCompletedTinea Infections Such as Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Mannum, Tinea Barbae, Tinea Capitis Are StudiedIndia
-
Sohag UniversityActive, not recruiting
-
PfizerCompleted
Clinical Trials on Apply Liquid Then Comb Out
-
University Hospital, Strasbourg, FranceRecruitingElectronic CigaretteFrance
-
Hôpital le VinatierNot yet recruitingBorderline Personality Disorder BPDFrance
-
University of RochesterEndo PharmaceuticalsTerminated
-
University of Vic - Central University of CataloniaRecruitingDiabetes Mellitus, Type 2 | Adherence, Patient | Physical InactivitySpain
-
University Hospital, BrestNovartis; Roche Pharma AG; Ministry of Health, France; Genzyme, a Sanofi CompanyCompleted